• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RCE 0.00% 46.0¢

RECCE PHARMACEUTICALS LTD - Announcements

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce... An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.More

Corporate Spotlight

An Emerging Global Leader in the New Generation of Anti-Infective Therapies. Recce Pharmaceuticals Ltd (ASX:RCE) is an Australian based globally-focussed, biotechnology company engaged in the development and commercialisation of a new class of synthetic anti-infectives.
View the full Corporate Spotlight arrow Created with Sketch.

RCE receives grant from US Department of Defence

Announcements


RCE Annual Report to shareholders31/08/21 download Created with Sketch. 5.72MB
RCE Appendix 4EPRICE SENSITIVE31/08/21 download Created with Sketch. 261.73KB
RCE Change in substantial holding16/08/21 download Created with Sketch. 215.74KB
RCE Recce Receives Further Innovation Connections GrantPRICE SENSITIVE11/08/21 download Created with Sketch. 225.61KB
RCE Appendix 4C and Activity ReportPRICE SENSITIVE30/07/21 download Created with Sketch. 433.45KB
RCE Corporate Presentation27/07/21 download Created with Sketch. 4.64MB
RCE Anti-Viral Patent Granted in USA for RECCE Anti-InfectivesPRICE SENSITIVE22/07/21 download Created with Sketch. 270.51KB
RCE Anti-Viral Patent Granted in ChinaPRICE SENSITIVE20/07/21 download Created with Sketch. 270.49KB
RCE Outstanding Efficacy Against Flesh-Eating BacteriaPRICE SENSITIVE19/07/21 download Created with Sketch. 423.92KB
RCE Multiple Patients Dosed in Topical Phase I/II Clinical TrialPRICE SENSITIVE12/07/21 download Created with Sketch. 296.93KB
RCE Bonus Canadian R&D Rebate Received05/07/21 download Created with Sketch. 267.77KB
RCE Change of Director's Interest Notices - J Graham & M Dilizia22/06/21 download Created with Sketch. 436.83KB
RCE Recce Pharmaceuticals to Present at World Microbe Forum18/06/21 download Created with Sketch. 307.62KB
RCE Recce to Present at MST Access Investor Conference17/06/21 download Created with Sketch. 4.88MB
RCE Corporate Presentation - EU Non-Deal Roadshow07/06/21 download Created with Sketch. 3.94MB
RCE Recce Clinical Pipeline UpdatePRICE SENSITIVE07/06/21 download Created with Sketch. 291.67KB
RCE R327 Demonstrates World First Multiple Mechanisms of ActionPRICE SENSITIVE27/05/21 download Created with Sketch. 1.26MB
RCE R327 to Stage 2 of SARS-CoV-2 Antiviral Screening at CSIROPRICE SENSITIVE19/05/21 download Created with Sketch. 328.14KB
RCE Positive Data on RECCE 327 Against All Six ESKAPE PathogensPRICE SENSITIVE04/05/21 download Created with Sketch. 883.37KB
RCE Appendix 4C and Activity ReportPRICE SENSITIVE27/04/21 download Created with Sketch. 453.68KB
RCE RECCE 327 Registered for Topical Burns Study in HumansPRICE SENSITIVE15/04/21 download Created with Sketch. 296.62KB
RCE Positive Sinusitis Patient Update - Special Access SchemePRICE SENSITIVE07/04/21 download Created with Sketch. 300.36KB
RCE Positive Sinusitis Data Against InfectionPRICE SENSITIVE01/04/21 download Created with Sketch. 618KB
RCE Anti-Viral Patent Granted in EU for RECCE Anti-InfectivesPRICE SENSITIVE30/03/21 download Created with Sketch. 228.62KB
RCE Pew Charitable Trusts adds R327 to Antibiotic Treatment List15/03/21 download Created with Sketch. 347.32KB
RCE S&P DJI Announces March 2021 Quarterly RebalancePRICE SENSITIVE12/03/21 download Created with Sketch. 183.24KB
RCE Recce Presenting at H.C. Wainwright Life Sciences Conference10/03/21 download Created with Sketch. 3.41MB
RCE Recce Pharmaceuticals Dual Lists on Frankfurt Stock ExchangePRICE SENSITIVE08/03/21 download Created with Sketch. 329.63KB
RCE Change of Director's Interest Notice25/02/21 download Created with Sketch. 209.76KB
RCE Change of Director's Interest Notice25/02/21 download Created with Sketch. 208.19KB
RCE Change of Director's Interest Notice25/02/21 download Created with Sketch. 179.73KB
RCE Change of Director's Interest Notice25/02/21 download Created with Sketch. 179.47KB
RCE Change of Director's Interest Notice25/02/21 download Created with Sketch. 212.36KB
RCE Cleansing Statement25/02/21 download Created with Sketch. 244.43KB
RCE Appendix 2A25/02/21 download Created with Sketch. 267.75KB
RCE Appendix 4D and Half Yearly ReportPRICE SENSITIVE25/02/21 download Created with Sketch. 451.22KB
RCE Recce Applies for Dual Listing on Frankfurt Stock ExchangePRICE SENSITIVE24/02/21 download Created with Sketch. 325.24KB
RCE Appendix 3G22/02/21 download Created with Sketch. 269.88KB
RCE Fiona Stanley Hospital Phase I/II Clinical Trial AgreementPRICE SENSITIVE16/02/21 download Created with Sketch. 413.46KB
RCE Further Encouraging COVID Results at DohertyPRICE SENSITIVE12/02/21 download Created with Sketch. 409.16KB
RCE R&D Incentive Rebate ReceivedPRICE SENSITIVE03/02/21 download Created with Sketch. 324.6KB
RCE Appendix 4C and Activity ReportPRICE SENSITIVE28/01/21 download Created with Sketch. 531.85KB
RCE Cleansing Statement19/01/21 download Created with Sketch. 260.03KB
RCE Appendix 2A19/01/21 download Created with Sketch. 198.8KB
RCE Corporate Presentation08/01/21 download Created with Sketch. 4.54MB
RCE Positive Intranasal Animal Data against SARS-CoV-2 in StudyPRICE SENSITIVE23/12/20 download Created with Sketch. 542.82KB
RCE Business Update16/12/20 download Created with Sketch. 435.35KB
RCE Change of Director's Interest Notice11/12/20 download Created with Sketch. 392.36KB
RCE RCE Awarded AusIndustry Advanced Overseas Anti-Viral FindingPRICE SENSITIVE08/12/20 download Created with Sketch. 370.39KB
RCE Cleansing Statement04/12/20 download Created with Sketch. 208.67KB
RCE Appendix 2A04/12/20 download Created with Sketch. 219.93KB
RCE Results of Meeting30/11/20 download Created with Sketch. 211.5KB
RCE RCE AGM Presentation30/11/20 download Created with Sketch. 3.03MB
RCE Recce Awarded AusIndustry Advanced Overseas (R&D) FindingPRICE SENSITIVE26/11/20 download Created with Sketch. 331.4KB
RCE Anti-Viral Patent Granted in Japan for RECCE Anti-InfectivesPRICE SENSITIVE23/11/20 download Created with Sketch. 297.82KB
RCE Reinstatement to Official QuotationPRICE SENSITIVE10/11/20 download Created with Sketch. 400.35KB
RCE Encouraging Results Against SARS-CoV-2 VirusPRICE SENSITIVE10/11/20 download Created with Sketch. 454.28KB
RCE Extension of Voluntary Suspension10/11/20 download Created with Sketch. 250.63KB
RCE Extension of Voluntary Suspension09/11/20 download Created with Sketch. 248.75KB
RCE Suspension from Official QuotationPRICE SENSITIVE05/11/20 download Created with Sketch. 422.52KB
RCE Trading HaltPRICE SENSITIVE03/11/20 download Created with Sketch. 465.12KB
RCE Letter to Shareholders - Annual General Meeting30/10/20 download Created with Sketch. 327.93KB
RCE Notice of Annual General Meeting/Proxy Form30/10/20 download Created with Sketch. 1.68MB
RCE Investor Presentation30/10/20 download Created with Sketch. 4.17MB
RCE Appendix 4C and Activity ReportPRICE SENSITIVE21/10/20 download Created with Sketch. 797.75KB
RCE HREC Approval to Start Phase I/II Burns Wound StudyPRICE SENSITIVE16/10/20 download Created with Sketch. 331.16KB
RCE Trading HaltPRICE SENSITIVE14/10/20 download Created with Sketch. 465.67KB
RCE Pause in tradingPRICE SENSITIVE14/10/20 download Created with Sketch. 116.3KB
RCE R&D Incentive Rebate ReceivedPRICE SENSITIVE05/10/20 download Created with Sketch. 316.17KB
RCE Change in substantial holding30/09/20 download Created with Sketch. 259.51KB
RCE Top 20 Shareholders Update30/09/20 download Created with Sketch. 221.66KB
RCE Appendix 3G30/09/20 download Created with Sketch. 266.47KB
RCE Cleansing Statement30/09/20 download Created with Sketch. 253.02KB
RCE Appendix 2A30/09/20 download Created with Sketch. 283.72KB
RCE Appendix 2A30/09/20 download Created with Sketch. 282.82KB
RCE Issue of Placement Shares30/09/20 download Created with Sketch. 354.66KB
RCE 2020 Annual General Meeting30/09/20 download Created with Sketch. 314.66KB
RCE Recce Appoints Michele Dilizia as Chief Scientific Officer30/09/20 download Created with Sketch. 349.78KB
RCE Murdoch Children's Research Institute, R435 Against H.PyloriPRICE SENSITIVE30/09/20 download Created with Sketch. 377.28KB
RCE Proposed issue of Securities - RCE23/09/20 download Created with Sketch. 27.68KB
RCE Recce Completes Capital Raising of $27.95mPRICE SENSITIVE23/09/20 download Created with Sketch. 350.89KB
RCE Trading HaltPRICE SENSITIVE21/09/20 download Created with Sketch. 507.12KB
RCE R327 Phase I Study - Australia's CMAX Clinical FacilityPRICE SENSITIVE10/09/20 download Created with Sketch. 377.7KB
RCE Comment on Media Article Published in AFR08/09/20 download Created with Sketch. 251.09KB
RCE Positive & Concentration-Dependent Efficacy Against COVID-19PRICE SENSITIVE08/09/20 download Created with Sketch. 621.04KB
RCE Trading HaltPRICE SENSITIVE07/09/20 download Created with Sketch. 649.24KB
RCE Pause in TradingPRICE SENSITIVE07/09/20 download Created with Sketch. 116.3KB
RCE Change of Director's Interest Notice02/09/20 download Created with Sketch. 216.89KB
RCE Change of Director's Interest Notice02/09/20 download Created with Sketch. 214.24KB
RCE Recce Pharmaceuticals Receives Innovation Connections GrantPRICE SENSITIVE01/09/20 download Created with Sketch. 309.07KB
RCE Cleansing Statement28/08/20 download Created with Sketch. 174.52KB
RCE Appendix 2A28/08/20 download Created with Sketch. 77.11KB
RCE Appendix 4G28/08/20 download Created with Sketch. 186.27KB
RCE 2020 Annual Report28/08/20 download Created with Sketch. 2.56MB
RCE Appendix 4EPRICE SENSITIVE28/08/20 download Created with Sketch. 209.81KB
RCE Recce Pharmaceuticals Appoints James Graham as CEOPRICE SENSITIVE28/08/20 download Created with Sketch. 370.03KB
RCE Appointment of H. Pylori Expert Prof Sutton to Dev Program21/08/20 download Created with Sketch. 342.2KB
RCE Conversion of Performance Shares17/08/20 download Created with Sketch. 343.59KB
RCE Investor Presentation04/08/20 download Created with Sketch. 3.87MB
RCE Positive Oral Data on New RECCE 435 Against H. pyloriPRICE SENSITIVE04/08/20 download Created with Sketch. 757.45KB
RCE Annual Report to shareholders
31/08/21 download Created with Sketch. 5.72MB
RCE Appendix 4E
31/08/21PRICE SENSITIVE download Created with Sketch. 261.73KB
RCE Change in substantial holding
16/08/21 download Created with Sketch. 215.74KB
RCE Recce Receives Further Innovation Connections Grant
11/08/21PRICE SENSITIVE download Created with Sketch. 225.61KB
RCE Appendix 4C and Activity Report
30/07/21PRICE SENSITIVE download Created with Sketch. 433.45KB
RCE Corporate Presentation
27/07/21 download Created with Sketch. 4.64MB
RCE Anti-Viral Patent Granted in USA for RECCE Anti-Infectives
22/07/21PRICE SENSITIVE download Created with Sketch. 270.51KB
RCE Anti-Viral Patent Granted in China
20/07/21PRICE SENSITIVE download Created with Sketch. 270.49KB
RCE Outstanding Efficacy Against Flesh-Eating Bacteria
19/07/21PRICE SENSITIVE download Created with Sketch. 423.92KB
RCE Multiple Patients Dosed in Topical Phase I/II Clinical Trial
12/07/21PRICE SENSITIVE download Created with Sketch. 296.93KB
RCE Bonus Canadian R&D Rebate Received
05/07/21 download Created with Sketch. 267.77KB
RCE Change of Director's Interest Notices - J Graham & M Dilizia
22/06/21 download Created with Sketch. 436.83KB
RCE Recce Pharmaceuticals to Present at World Microbe Forum
18/06/21 download Created with Sketch. 307.62KB
RCE Recce to Present at MST Access Investor Conference
17/06/21 download Created with Sketch. 4.88MB
RCE Corporate Presentation - EU Non-Deal Roadshow
07/06/21 download Created with Sketch. 3.94MB
RCE Recce Clinical Pipeline Update
07/06/21PRICE SENSITIVE download Created with Sketch. 291.67KB
RCE R327 Demonstrates World First Multiple Mechanisms of Action
27/05/21PRICE SENSITIVE download Created with Sketch. 1.26MB
RCE R327 to Stage 2 of SARS-CoV-2 Antiviral Screening at CSIRO
19/05/21PRICE SENSITIVE download Created with Sketch. 328.14KB
RCE Positive Data on RECCE 327 Against All Six ESKAPE Pathogens
04/05/21PRICE SENSITIVE download Created with Sketch. 883.37KB
RCE Appendix 4C and Activity Report
27/04/21PRICE SENSITIVE download Created with Sketch. 453.68KB
RCE RECCE 327 Registered for Topical Burns Study in Humans
15/04/21PRICE SENSITIVE download Created with Sketch. 296.62KB
RCE Positive Sinusitis Patient Update - Special Access Scheme
07/04/21PRICE SENSITIVE download Created with Sketch. 300.36KB
RCE Positive Sinusitis Data Against Infection
01/04/21PRICE SENSITIVE download Created with Sketch. 618KB
RCE Anti-Viral Patent Granted in EU for RECCE Anti-Infectives
30/03/21PRICE SENSITIVE download Created with Sketch. 228.62KB
RCE Pew Charitable Trusts adds R327 to Antibiotic Treatment List
15/03/21 download Created with Sketch. 347.32KB
RCE S&P DJI Announces March 2021 Quarterly Rebalance
12/03/21PRICE SENSITIVE download Created with Sketch. 183.24KB
RCE Recce Presenting at H.C. Wainwright Life Sciences Conference
10/03/21 download Created with Sketch. 3.41MB
RCE Recce Pharmaceuticals Dual Lists on Frankfurt Stock Exchange
08/03/21PRICE SENSITIVE download Created with Sketch. 329.63KB
RCE Change of Director's Interest Notice
25/02/21 download Created with Sketch. 209.76KB
RCE Change of Director's Interest Notice
25/02/21 download Created with Sketch. 208.19KB
RCE Change of Director's Interest Notice
25/02/21 download Created with Sketch. 179.73KB
RCE Change of Director's Interest Notice
25/02/21 download Created with Sketch. 179.47KB
RCE Change of Director's Interest Notice
25/02/21 download Created with Sketch. 212.36KB
RCE Cleansing Statement
25/02/21 download Created with Sketch. 244.43KB
RCE Appendix 2A
25/02/21 download Created with Sketch. 267.75KB
RCE Appendix 4D and Half Yearly Report
25/02/21PRICE SENSITIVE download Created with Sketch. 451.22KB
RCE Recce Applies for Dual Listing on Frankfurt Stock Exchange
24/02/21PRICE SENSITIVE download Created with Sketch. 325.24KB
RCE Appendix 3G
22/02/21 download Created with Sketch. 269.88KB
RCE Fiona Stanley Hospital Phase I/II Clinical Trial Agreement
16/02/21PRICE SENSITIVE download Created with Sketch. 413.46KB
RCE Further Encouraging COVID Results at Doherty
12/02/21PRICE SENSITIVE download Created with Sketch. 409.16KB
RCE R&D Incentive Rebate Received
03/02/21PRICE SENSITIVE download Created with Sketch. 324.6KB
RCE Appendix 4C and Activity Report
28/01/21PRICE SENSITIVE download Created with Sketch. 531.85KB
RCE Cleansing Statement
19/01/21 download Created with Sketch. 260.03KB
RCE Appendix 2A
19/01/21 download Created with Sketch. 198.8KB
RCE Corporate Presentation
08/01/21 download Created with Sketch. 4.54MB
RCE Positive Intranasal Animal Data against SARS-CoV-2 in Study
23/12/20PRICE SENSITIVE download Created with Sketch. 542.82KB
RCE Business Update
16/12/20 download Created with Sketch. 435.35KB
RCE Change of Director's Interest Notice
11/12/20 download Created with Sketch. 392.36KB
RCE RCE Awarded AusIndustry Advanced Overseas Anti-Viral Finding
08/12/20PRICE SENSITIVE download Created with Sketch. 370.39KB
RCE Cleansing Statement
04/12/20 download Created with Sketch. 208.67KB
RCE Appendix 2A
04/12/20 download Created with Sketch. 219.93KB
RCE Results of Meeting
30/11/20 download Created with Sketch. 211.5KB
RCE RCE AGM Presentation
30/11/20 download Created with Sketch. 3.03MB
RCE Recce Awarded AusIndustry Advanced Overseas (R&D) Finding
26/11/20PRICE SENSITIVE download Created with Sketch. 331.4KB
RCE Anti-Viral Patent Granted in Japan for RECCE Anti-Infectives
23/11/20PRICE SENSITIVE download Created with Sketch. 297.82KB
RCE Reinstatement to Official Quotation
10/11/20PRICE SENSITIVE download Created with Sketch. 400.35KB
RCE Encouraging Results Against SARS-CoV-2 Virus
10/11/20PRICE SENSITIVE download Created with Sketch. 454.28KB
RCE Extension of Voluntary Suspension
10/11/20 download Created with Sketch. 250.63KB
RCE Extension of Voluntary Suspension
09/11/20 download Created with Sketch. 248.75KB
RCE Suspension from Official Quotation
05/11/20PRICE SENSITIVE download Created with Sketch. 422.52KB
RCE Trading Halt
03/11/20PRICE SENSITIVE download Created with Sketch. 465.12KB
RCE Letter to Shareholders - Annual General Meeting
30/10/20 download Created with Sketch. 327.93KB
RCE Notice of Annual General Meeting/Proxy Form
30/10/20 download Created with Sketch. 1.68MB
RCE Investor Presentation
30/10/20 download Created with Sketch. 4.17MB
RCE Appendix 4C and Activity Report
21/10/20PRICE SENSITIVE download Created with Sketch. 797.75KB
RCE HREC Approval to Start Phase I/II Burns Wound Study
16/10/20PRICE SENSITIVE download Created with Sketch. 331.16KB
RCE Trading Halt
14/10/20PRICE SENSITIVE download Created with Sketch. 465.67KB
RCE Pause in trading
14/10/20PRICE SENSITIVE download Created with Sketch. 116.3KB
RCE R&D Incentive Rebate Received
05/10/20PRICE SENSITIVE download Created with Sketch. 316.17KB
RCE Change in substantial holding
30/09/20 download Created with Sketch. 259.51KB
RCE Top 20 Shareholders Update
30/09/20 download Created with Sketch. 221.66KB
RCE Appendix 3G
30/09/20 download Created with Sketch. 266.47KB
RCE Cleansing Statement
30/09/20 download Created with Sketch. 253.02KB
RCE Appendix 2A
30/09/20 download Created with Sketch. 283.72KB
RCE Appendix 2A
30/09/20 download Created with Sketch. 282.82KB
RCE Issue of Placement Shares
30/09/20 download Created with Sketch. 354.66KB
RCE 2020 Annual General Meeting
30/09/20 download Created with Sketch. 314.66KB
RCE Recce Appoints Michele Dilizia as Chief Scientific Officer
30/09/20 download Created with Sketch. 349.78KB
RCE Murdoch Children's Research Institute, R435 Against H.Pylori
30/09/20PRICE SENSITIVE download Created with Sketch. 377.28KB
RCE Proposed issue of Securities - RCE
23/09/20 download Created with Sketch. 27.68KB
RCE Recce Completes Capital Raising of $27.95m
23/09/20PRICE SENSITIVE download Created with Sketch. 350.89KB
RCE Trading Halt
21/09/20PRICE SENSITIVE download Created with Sketch. 507.12KB
RCE R327 Phase I Study - Australia's CMAX Clinical Facility
10/09/20PRICE SENSITIVE download Created with Sketch. 377.7KB
RCE Comment on Media Article Published in AFR
08/09/20 download Created with Sketch. 251.09KB
RCE Positive & Concentration-Dependent Efficacy Against COVID-19
08/09/20PRICE SENSITIVE download Created with Sketch. 621.04KB
RCE Trading Halt
07/09/20PRICE SENSITIVE download Created with Sketch. 649.24KB
RCE Pause in Trading
07/09/20PRICE SENSITIVE download Created with Sketch. 116.3KB
RCE Change of Director's Interest Notice
02/09/20 download Created with Sketch. 216.89KB
RCE Change of Director's Interest Notice
02/09/20 download Created with Sketch. 214.24KB
RCE Recce Pharmaceuticals Receives Innovation Connections Grant
01/09/20PRICE SENSITIVE download Created with Sketch. 309.07KB
RCE Cleansing Statement
28/08/20 download Created with Sketch. 174.52KB
RCE Appendix 2A
28/08/20 download Created with Sketch. 77.11KB
RCE Appendix 4G
28/08/20 download Created with Sketch. 186.27KB
RCE 2020 Annual Report
28/08/20 download Created with Sketch. 2.56MB
RCE Appendix 4E
28/08/20PRICE SENSITIVE download Created with Sketch. 209.81KB
RCE Recce Pharmaceuticals Appoints James Graham as CEO
28/08/20PRICE SENSITIVE download Created with Sketch. 370.03KB
RCE Appointment of H. Pylori Expert Prof Sutton to Dev Program
21/08/20 download Created with Sketch. 342.2KB
RCE Conversion of Performance Shares
17/08/20 download Created with Sketch. 343.59KB
RCE Investor Presentation
04/08/20 download Created with Sketch. 3.87MB
RCE Positive Oral Data on New RECCE 435 Against H. pylori
04/08/20PRICE SENSITIVE download Created with Sketch. 757.45KB
(20min delay)
Last
46.0¢
Change
0.000(0.00%)
Mkt cap ! $102.0M
Open High Low Value Volume
46.0¢ 46.5¢ 46.0¢ $19.60K 42.56K

Buyers (Bids)

No. Vol. Price($)
3 41004 46.0¢
 

Sellers (Offers)

Price($) Vol. No.
46.5¢ 38272 2
View Market Depth
Last trade - 15.56pm 26/07/2024 (20 minute delay) ?
Last
46.0¢
  Change
0.000 ( 1.08 %)
Open High Low Volume
46.0¢ 47.0¢ 46.0¢ 5566
Last updated 12.56pm 26/07/2024 ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.